CD34 and chronic myelogenous leukemia, BCR-ABL1 positive: In CML, CFCs were significantly decreased in all treatment arms with less colonies observed following combination treatment (Fig. 5d–ii, iii) with no significant effects on normal CD34+ (Fig. 5d–i).